IPO Schedule
1
Open
11 Nov
2
Close
13 Nov
3
Allotment
14 Nov
4
Listing
18 Nov
Mahamaya Lifesciences Ltd IPO
Issue:₹114
List:₹116
CMP:₹195
NSELot: 1200Fertilizers
LISTEDSME
Issue Price₹114
Listing₹116
Current₹195
Content
About Mahamaya Lifesciences Ltd
Mahamaya Lifesciences Ltd. is an Indian pharmaceutical company focused on manufacturing and marketing generic pharmaceutical products. They operate primarily in the domestic market, catering to various therapeutic segments.
Subscription Status
QIB
0.00x
NII
0.35x
Retail
0.07x
| Category | Day 3 | Day 2 | Day 1 |
|---|---|---|---|
| QIB | 1.19x | 0.65x | 0.00x |
| NII | 3.63x | 0.27x | 0.35x |
| Retail | 1.02x | 0.20x | 0.07x |
| Total | 1.63x | 0.34x | 0.11x |
Risk Factors
•SME IPOs are inherently more volatile than mainboard IPOs.
•Dependence on the domestic market exposes the company to regulatory changes and competitive pressures within India's pharmaceutical sector.
•The generic pharmaceutical industry is highly competitive, requiring constant innovation and cost management.
Promoters & Management
The management team is led by Mr. Krishnamurthy Ganesan, the Managing Director, who has over 22 years of experience in the agrochemical sector. He is responsible for overseeing the company's operations and strategy. Mrs. Lalitha Krishnamurthy, Whole-time Director, oversees human resources and legal matters. Mr. Prashant Krishnamurthy, Executive Director and CFO, leads day-to-day operations and ensures the company's performance aligns with its goals. He oversees procurement, production, commercial, finance, and sales & marketing. Ms. Shilpi Bhardwaj is the Company Secretary and Compliance Officer, responsible for overseeing compliances. The senior management team consists of professionals with expertise in developing, marketing, and distributing the company's products.